These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33379411)

  • 21. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of Potential Drug-Eluting Contact Lens Technologies.
    Lovrec-Krstič T; Orthaber K; Maver U; Sarenac T
    Materials (Basel); 2023 May; 16(10):. PubMed ID: 37241280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular Drug Delivery: Present Innovations and Future Challenges.
    Gote V; Sikder S; Sicotte J; Pal D
    J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic applications of contact lens-based drug delivery systems in ophthalmic diseases.
    Zhao L; Song J; Du Y; Ren C; Guo B; Bi H
    Drug Deliv; 2023 Dec; 30(1):2219419. PubMed ID: 37264930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the clinical applications of drug delivery systems for the treatment of ocular anterior segment inflammation.
    Wong CW; Metselaar JM; Storm G; Wong TT
    Br J Ophthalmol; 2021 Dec; 105(12):1617-1622. PubMed ID: 33127826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Physiology-Based Mathematical Model to Understand Drug Delivery from Contact Lenses to the Back of the Eye.
    Toffoletto N; Saramago B; Serro AP; Chauhan A
    Pharm Res; 2023 Aug; 40(8):1939-1951. PubMed ID: 37498499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.
    Wang Y; Wang C
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic prodrug and codrug design and delivery.
    Babizhayev MA
    Drug Dev Ind Pharm; 2008 Oct; 34(10):1071-89. PubMed ID: 18777243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive review on contact lens for ophthalmic drug delivery.
    Xu J; Xue Y; Hu G; Lin T; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2018 Jul; 281():97-118. PubMed ID: 29782944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic contact lenses: a patent review.
    Dixon P; Shafor C; Gause S; Hsu KH; Powell KC; Chauhan A
    Expert Opin Ther Pat; 2015; 25(10):1117-29. PubMed ID: 26143943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ophthalmic Drug Delivery Systems for Antibiotherapy-A Review.
    Dubald M; Bourgeois S; Andrieu V; Fessi H
    Pharmaceutics; 2018 Jan; 10(1):. PubMed ID: 29342879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commercialization challenges for drug eluting contact lenses.
    Lanier OL; Christopher KG; Macoon RM; Yu Y; Sekar P; Chauhan A
    Expert Opin Drug Deliv; 2020 Aug; 17(8):1133-1149. PubMed ID: 32602822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(14):1-120. PubMed ID: 23074518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained drug release by contact lenses for glaucoma treatment-a review.
    Carvalho IM; Marques CS; Oliveira RS; Coelho PB; Costa PC; Ferreira DC
    J Control Release; 2015 Mar; 202():76-82. PubMed ID: 25617723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended drug delivery by contact lenses for glaucoma therapy.
    Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
    J Control Release; 2012 Aug; 162(1):152-8. PubMed ID: 22721817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review on therapeutic contact lenses for ocular drug delivery.
    Maulvi FA; Soni TG; Shah DO
    Drug Deliv; 2016 Oct; 23(8):3017-3026. PubMed ID: 26821766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
    Hehl EM; Beck R; Luthard K; Guthoff R; Drewelow B
    Eur J Clin Pharmacol; 1999 Jun; 55(4):317-23. PubMed ID: 10424326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.